Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol.

Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia. Haematologica (2015) 0.96

Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms. Diagn Pathol (2016) 0.82

Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients. Oncotarget (2016) 0.80

A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma. Blood Cancer J (2016) 0.78

Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies. Blood (2016) 0.76

Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia. Blood Cancer J (2017) 0.75

Diagnosis and classification of hematologic malignancies on the basis of genetics. Blood (2017) 0.75

DNMT3A mutations in Chinese childhood acute myeloid leukemia. Medicine (Baltimore) (2017) 0.75

Accurate whole human genome sequencing using reversible terminator chemistry. Nature (2008) 90.20

An integrated map of genetic variation from 1,092 human genomes. Nature (2012) 59.82

BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics (2010) 53.23

Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics (2010) 52.01

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature (2008) 38.13

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood (2009) 23.52

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med (2013) 19.87

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood (2009) 15.95

Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics (2009) 15.08

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature (2012) 14.33

Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol (1976) 13.98

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med (2008) 13.02

Discovery and saturation analysis of cancer genes across 21 tumour types. Nature (2014) 11.68

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med (2012) 10.20

Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature (2014) 6.83

Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood (2013) 6.50

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations. Blood (2005) 4.60

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia (2013) 3.93

Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis. Nat Genet (2012) 3.33

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun (2014) 3.12

Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms. Blood (2010) 2.61

Functional heterogeneity of genetically defined subclones in acute myeloid leukemia. Cancer Cell (2014) 2.15

Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data. J Mol Diagn (2012) 2.02

Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study. Blood (2005) 1.87

Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? Blood (2010) 1.80

Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome. J Clin Oncol (2009) 1.73

Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring. Haematologica (2013) 1.37

C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice. Proc Natl Acad Sci U S A (2011) 1.36

FLT3 inhibition: a moving and evolving target in acute myeloid leukaemia. Leukemia (2012) 1.24

The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplication. Blood (2009) 1.15

Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture. Leukemia (2013) 0.96

Accurate detection of subclonal single nucleotide variants in whole genome amplified and pooled cancer samples using HaloPlex target enrichment. BMC Genomics (2013) 0.92

Robust in vivo differentiation of t(8;21)-positive acute myeloid leukemia blasts to neutrophilic granulocytes induced by treatment with dasatinib. Leukemia (2010) 0.83

Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat Genet (2014) 5.74

Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science (2014) 5.63

A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer. Nat Med (2014) 1.05

Calreticulin mutations in myeloproliferative neoplasms and new methodology for their detection and monitoring. Ann Hematol (2014) 0.83

cDNA synthesis for BCR-ABL1 detection at the MMR level: the importance of using the appropriate kit. Biol Proced Online (2015) 0.75